Annual total expenses:
$285.42M+$112.55M(+65.11%)Summary
- As of today (June 21, 2025), AKRO annual total expenses is $285.42 million, with the most recent change of +$112.55 million (+65.11%) on December 31, 2024.
- During the last 3 years, AKRO annual total expenses has risen by +$184.54 million (+182.92%).
- AKRO annual total expenses is now at all-time high.
Performance
AKRO Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$80.88M+$2.86M(+3.66%)Summary
- As of today (June 21, 2025), AKRO quarterly total expenses is $80.88 million, with the most recent change of +$2.86 million (+3.66%) on March 31, 2025.
- Over the past year, AKRO quarterly total expenses has increased by +$20.93 million (+34.91%).
- AKRO quarterly total expenses is now -1.00% below its all-time high of $81.70 million, reached on September 30, 2024.
Performance
AKRO Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AKRO Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +65.1% | +34.9% |
3 y3 years | +182.9% | +210.5% |
5 y5 years | +525.2% | +553.4% |
AKRO Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +182.9% | -1.0% | +218.2% |
5 y | 5-year | at high | +525.2% | -1.0% | +553.4% |
alltime | all time | at high | +1971.6% | -1.0% | >+9999.0% |
AKRO Total expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $80.88M(+3.7%) |
Dec 2024 | $285.42M(+65.1%) | $78.03M(-4.5%) |
Sep 2024 | - | $81.70M(+24.3%) |
Jun 2024 | - | $65.74M(+9.7%) |
Mar 2024 | - | $59.95M(-3.1%) |
Dec 2023 | $172.87M(+50.1%) | $61.87M(+32.7%) |
Sep 2023 | - | $46.62M(+30.8%) |
Jun 2023 | - | $35.63M(+23.9%) |
Mar 2023 | - | $28.75M(+13.1%) |
Dec 2022 | $115.16M(+14.1%) | $25.42M(-29.6%) |
Sep 2022 | - | $36.09M(+30.8%) |
Jun 2022 | - | $27.59M(+5.9%) |
Mar 2022 | - | $26.05M(-19.7%) |
Dec 2021 | $100.89M | $32.44M(+33.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $24.35M(-15.9%) |
Jun 2021 | - | $28.97M(+91.5%) |
Mar 2021 | - | $15.13M(-49.2%) |
Dec 2020 | $80.15M(+75.6%) | $29.78M(+38.3%) |
Sep 2020 | - | $21.54M(+30.9%) |
Jun 2020 | - | $16.45M(+32.9%) |
Mar 2020 | - | $12.38M(-23.7%) |
Dec 2019 | $45.65M(+231.3%) | $16.22M(-0.5%) |
Sep 2019 | - | $16.31M(+114.3%) |
Jun 2019 | - | $7.61M(+38.0%) |
Mar 2019 | - | $5.51M(+85.7%) |
Dec 2018 | $13.78M | $2.97M(+71.9%) |
Sep 2018 | - | $1.73M(-80.1%) |
Jun 2018 | - | $8.66M(+1957.5%) |
Mar 2018 | - | $421.00K |
FAQ
- What is Akero Therapeutics annual total expenses?
- What is the all time high annual total expenses for Akero Therapeutics?
- What is Akero Therapeutics annual total expenses year-on-year change?
- What is Akero Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Akero Therapeutics?
- What is Akero Therapeutics quarterly total expenses year-on-year change?
What is Akero Therapeutics annual total expenses?
The current annual total expenses of AKRO is $285.42M
What is the all time high annual total expenses for Akero Therapeutics?
Akero Therapeutics all-time high annual total expenses is $285.42M
What is Akero Therapeutics annual total expenses year-on-year change?
Over the past year, AKRO annual total expenses has changed by +$112.55M (+65.11%)
What is Akero Therapeutics quarterly total expenses?
The current quarterly total expenses of AKRO is $80.88M
What is the all time high quarterly total expenses for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total expenses is $81.70M
What is Akero Therapeutics quarterly total expenses year-on-year change?
Over the past year, AKRO quarterly total expenses has changed by +$20.93M (+34.91%)